Showing results (121-130 of 451) with videos related to
Sort By:
Pageof 46
Molecular Immunology|August 2, 2014
Maintaining dendritic cell viability in cultureDavid Vremec, Jacinta Hansen, Andreas Strasser, et al.Cancer Cell|December 12, 2018
BH3-Mimetic Drugs: Blazing the Trail for New Cancer MedicinesDelphine Merino, Gemma L Kelly, Guillaume Lessene, et al.Nature Communications|September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95LLucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.Nature|February 28, 2014
Is SIRT2 required for necroptosis?Kim Newton, Joanne M Hildebrand, Zhirong Shen, et al.Immunology and Cell Biology|October 9, 2013
Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1Nima Etemadi, Andrew Webb, Aleksandra Bankovacki, et al.Frontiers in Immunology|July 18, 2022
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric CancersYanhong Ni, Jun T Low, John Silke, et al.Trends in Immunology|November 9, 2021
Unleashing TNF cytotoxicity to enhance cancer immunotherapyAndrew J Freeman, Conor J Kearney, John Silke, et al.Oncogene|August 11, 2023
BCL-W makes only minor contributions to MYC-driven lymphoma developmentSarah T Diepstraten, John E La Marca, Catherine Chang, et al.The EMBO Journal|November 5, 2005
Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesisLeigh Coultas, Philippe Bouillet, Kate L Loveland, et al.Pageof 46